1. Home
  2. CLRB vs SHFS Comparison

CLRB vs SHFS Comparison

Compare CLRB & SHFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLRB
  • SHFS
  • Stock Information
  • Founded
  • CLRB 2002
  • SHFS 2015
  • Country
  • CLRB United States
  • SHFS United States
  • Employees
  • CLRB N/A
  • SHFS N/A
  • Industry
  • CLRB Biotechnology: Pharmaceutical Preparations
  • SHFS Finance: Consumer Services
  • Sector
  • CLRB Health Care
  • SHFS Finance
  • Exchange
  • CLRB Nasdaq
  • SHFS Nasdaq
  • Market Cap
  • CLRB 17.6M
  • SHFS 20.8M
  • IPO Year
  • CLRB N/A
  • SHFS N/A
  • Fundamental
  • Price
  • CLRB $4.98
  • SHFS $2.22
  • Analyst Decision
  • CLRB Hold
  • SHFS
  • Analyst Count
  • CLRB 2
  • SHFS 0
  • Target Price
  • CLRB N/A
  • SHFS N/A
  • AVG Volume (30 Days)
  • CLRB 1.3M
  • SHFS 9.3K
  • Earning Date
  • CLRB 08-12-2025
  • SHFS 08-13-2025
  • Dividend Yield
  • CLRB N/A
  • SHFS N/A
  • EPS Growth
  • CLRB N/A
  • SHFS N/A
  • EPS
  • CLRB N/A
  • SHFS N/A
  • Revenue
  • CLRB N/A
  • SHFS $13,956,453.00
  • Revenue This Year
  • CLRB N/A
  • SHFS N/A
  • Revenue Next Year
  • CLRB N/A
  • SHFS N/A
  • P/E Ratio
  • CLRB N/A
  • SHFS N/A
  • Revenue Growth
  • CLRB N/A
  • SHFS N/A
  • 52 Week Low
  • CLRB $4.36
  • SHFS $1.84
  • 52 Week High
  • CLRB $94.50
  • SHFS $14.86
  • Technical
  • Relative Strength Index (RSI)
  • CLRB 33.34
  • SHFS 46.90
  • Support Level
  • CLRB $6.50
  • SHFS $2.03
  • Resistance Level
  • CLRB $8.30
  • SHFS $2.36
  • Average True Range (ATR)
  • CLRB 1.42
  • SHFS 0.14
  • MACD
  • CLRB -0.66
  • SHFS 0.00
  • Stochastic Oscillator
  • CLRB 1.63
  • SHFS 53.21

About CLRB Cellectar Biosciences Inc.

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.

Share on Social Networks: